Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$37.11 - $50.69 $2,263 - $3,092
-61 Reduced 0.74%
8,155 $392,000
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $333,980 - $540,284
8,216 New
8,216 $394,000
Q2 2023

Aug 11, 2023

BUY
$56.23 - $71.17 $1.84 Million - $2.33 Million
32,671 Added 479.75%
39,481 $2.3 Million
Q1 2023

May 15, 2023

SELL
$53.43 - $68.12 $47,445 - $60,490
-888 Reduced 11.54%
6,810 $420,000
Q4 2022

Feb 14, 2023

SELL
$61.23 - $83.62 $547,457 - $747,646
-8,941 Reduced 53.74%
7,698 $489,000
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $806,306 - $1.04 Million
12,295 Added 283.03%
16,639 $1.25 Million
Q2 2022

Aug 11, 2022

BUY
$52.13 - $93.81 $226,452 - $407,510
4,344 New
4,344 $291,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.7B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.